Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Clinical trial NCT06056830 · RECRUITING
Trial details
- NCT number
- NCT06056830
- Sponsor
- Clarity Pharmaceuticals Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-21
- Primary completion
- 2026-09-01
- Enrollment
- 383
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.